Farms.com Home   News

Seeds Starting To Develop In Soybeans

 
Soybeans in Manitoba are quickly advancing.
 
Cassandra Tkachuk, production specialist with Manitoba Pulse and Soybean Growers (MPSG), explains where the crop is at.
 
"Currently soybean crops range from the R2 to R3 or even the R4 stages, with some of the earlier seeded fields," she said. "This is where pods and seeds are starting to develop in the lower canopy. Pod formation is well underway in dry beans and field peas are actually beginning to dry down in western Manitoba."
 
Tkachuk notes some crops were damaged by the hail that fell over the weekend. She says the R2 and R3 stage is the most sensitive to hail damage, adding yield losses can range anywhere from 42 to 65 per cent from 100 per cent defoliation, according to recent research results.
 
Farmers should be looking for post herbicide resistance, taking note of any weeds that escaped herbicide control. Producers should also be scouting for foliar diseases such as septoria brown spot, bacterial blight, downy mildew and white mold.
 
Source : Steinbachonline

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.